There are 2789 resources available
578MO - Phase Ib/II study of sabizabulin (VERU-111), an androgen receptor transport disruptor, in men with metastatic castration resistant prostate cancer (mCRPC) who failed an androgen receptor targeting agent (ARTA)
Presenter: Mark Markowski
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
829MO - A gene signature to predict risk of transformation in patients with follicular lymphoma
Presenter: Ismael Fernandez-Miranda
Session: Mini oral session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
LBA51 - EMPOWER-Lung 3: Cemiplimab in combination with platinum doublet chemotherapy for first-line (1L) treatment of advanced non-small cell lung cancer (NSCLC)
Presenter: Miranda Gogishvili
Session: Mini oral session - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
1194MO - Canakinumab (CAN) + docetaxel (DTX) for the second- or third-line (2/3L) treatment of advanced non-small cell lung cancer (NSCLC): CANOPY-2 phase III results
Presenter: Luis Paz-Ares
Session: Mini oral session - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
576MO - Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of <sup>177</sup>Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Presenter: Karim Fizazi
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Introduction by the chair
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Yes
Presenter: Denis Soulieres
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
No
Presenter: Paolo Bossi
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast
Q&A
Presenter: Kevin Harrington
Session: Can quality of life be a “hard” study endpoint in head and neck cancer?
Resources:
Slides
Webcast